Cystatin C serum levels in healthy children are related to age, gender, and pubertal stage.


Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
03 2019
Historique:
received: 23 04 2018
accepted: 12 09 2018
revised: 05 08 2018
pubmed: 22 11 2018
medline: 6 5 2020
entrez: 22 11 2018
Statut: ppublish

Résumé

This study aims to establish age- and gender-specific cystatin C (CysC) reference values for healthy infants, children, and adolescents and to relate them to pubertal stage, height, weight, and body mass index (BMI). Serum CysC and creatinine levels of 6217 fasting, morning venous blood samples from 2803 healthy participants of the LIFE Child study (age 3 months to 18 years) were analyzed by an immunoassay. Recruitment started in 2011; 1636 participants provided at least one follow-up measurement. Percentiles for CysC were calculated. Age- and gender-related effects of height, weight, BMI, and puberty status were assessed through linear regression models. Over the first 2 years of life, median CysC levels decrease depending on height (ß = - 0.010 mg/l/cm, p < 0.001) and weight (ß = - 0.033 mg/l/kg, p < 0.001) from 1.06 to 0.88 mg/l for males and from 1.04 to 0.87 mg/l for females. Following the second year of age, the levels remain stable for eight years. From 11 to 14 years of age, there is an increase of median CysC levels in males to 0.98 mg/l and a decrease in females to 0.86 mg/l. The change is associated with puberty (ß = 0.105 mg/l/Tanner stage, p < 0.001 in males and ß = - 0.093 mg/l/Tanner stage, p < 0.01 in females) and in males with height (ß = 0.003 mg/l/cm, p < 0.001). CysC levels depend on age, gender, and height, especially during infancy and puberty. We recommend the use of age- and gender-specific reference values for CysC serum levels for estimating kidney function in clinical practice.

Sections du résumé

BACKGROUND
This study aims to establish age- and gender-specific cystatin C (CysC) reference values for healthy infants, children, and adolescents and to relate them to pubertal stage, height, weight, and body mass index (BMI).
METHODS
Serum CysC and creatinine levels of 6217 fasting, morning venous blood samples from 2803 healthy participants of the LIFE Child study (age 3 months to 18 years) were analyzed by an immunoassay. Recruitment started in 2011; 1636 participants provided at least one follow-up measurement. Percentiles for CysC were calculated. Age- and gender-related effects of height, weight, BMI, and puberty status were assessed through linear regression models.
RESULTS
Over the first 2 years of life, median CysC levels decrease depending on height (ß = - 0.010 mg/l/cm, p < 0.001) and weight (ß = - 0.033 mg/l/kg, p < 0.001) from 1.06 to 0.88 mg/l for males and from 1.04 to 0.87 mg/l for females. Following the second year of age, the levels remain stable for eight years. From 11 to 14 years of age, there is an increase of median CysC levels in males to 0.98 mg/l and a decrease in females to 0.86 mg/l. The change is associated with puberty (ß = 0.105 mg/l/Tanner stage, p < 0.001 in males and ß = - 0.093 mg/l/Tanner stage, p < 0.01 in females) and in males with height (ß = 0.003 mg/l/cm, p < 0.001).
CONCLUSIONS
CysC levels depend on age, gender, and height, especially during infancy and puberty. We recommend the use of age- and gender-specific reference values for CysC serum levels for estimating kidney function in clinical practice.

Identifiants

pubmed: 30460495
doi: 10.1007/s00467-018-4087-z
pii: 10.1007/s00467-018-4087-z
pmc: PMC6349798
doi:

Substances chimiques

Biomarkers 0
CST3 protein, human 0
Cystatin C 0
Creatinine AYI8EX34EU

Banques de données

ClinicalTrials.gov
['NCT02550236']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

449-457

Références

Clin Biochem. 2016 Jul;49(10-11):740-9
pubmed: 26948098
Clin Chem. 2005 Nov;51(11):2215-6
pubmed: 16244312
Kidney Int. 1985 Nov;28(5):830-8
pubmed: 2418254
J Am Soc Nephrol. 2009 Mar;20(3):629-37
pubmed: 19158356
Eur J Epidemiol. 2017 Feb;32(2):145-158
pubmed: 28144813
Clin J Am Soc Nephrol. 2008 Nov;3(6):1777-85
pubmed: 18815241
Clin Exp Nephrol. 2011 Oct;15(5):694-699
pubmed: 21505953
Clin Biochem. 2016 Jan;49(1-2):150-3
pubmed: 26506118
Clin Chem Lab Med. 2015 Sep 1;53(10):1621-30
pubmed: 25719320
Kidney Int. 2004 Apr;65(4):1416-21
pubmed: 15086483
Scand J Clin Lab Invest. 2010 Feb;70(1):54-9
pubmed: 20073673
Pediatr Nephrol. 1999 Aug;13(6):506-9
pubmed: 10452279
Clin Exp Nephrol. 2013 Dec;17(6):872-6
pubmed: 23446519
Clin Chem Lab Med. 1998 Nov;36(11):859-65
pubmed: 9877092
Ann Clin Biochem. 1990 Mar;27 ( Pt 2):99-101
pubmed: 2327712
Epidemiology. 2007 Nov;18(6):805-35
pubmed: 18049195
Scand J Clin Lab Invest. 1999 Dec;59(8):587-92
pubmed: 10691049
Hepatology. 2018 Oct;68(4):1319-1330
pubmed: 28926121
Arch Dis Child. 1969 Jun;44(235):291-303
pubmed: 5785179
Biochem J. 1990 Jun 1;268(2):287-94
pubmed: 2363674
Clin Chem. 1999 Oct;45(10):1856-8
pubmed: 10508134
Lege Artis Med. 2014 Mar;24(3):152-8
pubmed: 25137984
Pediatr Nephrol. 2003 Oct;18(10):981-5
pubmed: 12920638
Clin Biochem. 2005 Jan;38(1):1-8
pubmed: 15607309
Arch Dis Child. 1970 Feb;45(239):13-23
pubmed: 5440182
Clin Chem. 1997 Jun;43(6 Pt 1):1077-8
pubmed: 9191564
Scand J Clin Lab Invest. 1996 Aug;56(5):409-14
pubmed: 8869663
Stat Med. 2016 Jun 30;35(14):2328-58
pubmed: 26822948
J Pediatr Endocrinol Metab. 2017 Jul 26;30(7):767-773
pubmed: 28586305
BMC Public Health. 2012 Nov 22;12:1021
pubmed: 23181778
Pediatr Nephrol. 1998 Feb;12(2):125-9
pubmed: 9543370
Am J Nephrol. 2017;45(4):320-326
pubmed: 28245441
Transplantation. 2008 Jul 27;86(2):245-50
pubmed: 18645486
Clin Chem Lab Med. 2012 Feb 29;50(5):845-51
pubmed: 22628328
Kidney Int. 2007 May;71(10):1028-35
pubmed: 17396113
Acta Med Scand. 1985;218(5):499-503
pubmed: 3911736
Pediatr Nephrol. 2009 May;24(5):929-41
pubmed: 18839216
Ann Clin Biochem. 1986 Jan;23 ( Pt 1):1-25
pubmed: 3532908
Biochem Biophys Res Commun. 1984 Jan 13;118(1):103-9
pubmed: 6365094
Clin Chem Lab Med. 2010 Nov;48(11):1619-21
pubmed: 21034257
Clin Chem. 1994 Oct;40(10):1921-6
pubmed: 7923773
Pediatr Nephrol. 2000 Nov;15(1-2):105-8
pubmed: 11095024
Arch Dis Child. 2000 Jan;82(1):71-5
pubmed: 10630919

Auteurs

Niels Ziegelasch (N)

LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig, Philipp-Rosenthal-Strasse 27, 04103, Leipzig, Germany.

Mandy Vogel (M)

LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig, Philipp-Rosenthal-Strasse 27, 04103, Leipzig, Germany.
Center of Paediatric Research (CPL), University of Leipzig, 04103, Leipzig, Germany.

Eva Müller (E)

LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig, Philipp-Rosenthal-Strasse 27, 04103, Leipzig, Germany.

Nadin Tremel (N)

LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig, Philipp-Rosenthal-Strasse 27, 04103, Leipzig, Germany.

Anne Jurkutat (A)

LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig, Philipp-Rosenthal-Strasse 27, 04103, Leipzig, Germany.

Markus Löffler (M)

Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, 04107, Leipzig, Germany.

Nicolas Terliesner (N)

Hospital for Children and Adolescents, University of Leipzig, Liebigstraße 20a, 04103, Leipzig, Germany.

Joachim Thiery (J)

Institute for Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics (ILM), University Hospital Leipzig, 04103, Leipzig, Germany.

Anja Willenberg (A)

Institute for Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics (ILM), University Hospital Leipzig, 04103, Leipzig, Germany.

Wieland Kiess (W)

LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig, Philipp-Rosenthal-Strasse 27, 04103, Leipzig, Germany.
Center of Paediatric Research (CPL), University of Leipzig, 04103, Leipzig, Germany.
Hospital for Children and Adolescents, University of Leipzig, Liebigstraße 20a, 04103, Leipzig, Germany.

Katalin Dittrich (K)

Center of Paediatric Research (CPL), University of Leipzig, 04103, Leipzig, Germany. katalin.dittrich@medizin.uni-leipzig.de.
Hospital for Children and Adolescents, University of Leipzig, Liebigstraße 20a, 04103, Leipzig, Germany. katalin.dittrich@medizin.uni-leipzig.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH